Advertisement
Research Article| Volume 21, ISSUE 3, P411-420, September 2001

Recent Challenges in Infectious Diseases: Biological Pathogens as Weapons and Emerging Endemic Threats

DOI:https://doi.org/10.1016/S0272-2712(18)30016-7
Recent Challenges in Infectious Diseases: Biological Pathogens as Weapons and Emerging Endemic Threats
Previous ArticlePreface
Next ArticleHistory of the Development and Use of Biological Weapons
      This paper is only available as a PDF. To read, Please Download here.
      This article reviews emerging and re-emerging infectious diseases and provides insights regarding the evolution of our understanding of natural diseases and how that knowledge impacts the development of plans and methods for defending against the deliberate use of biological agents. Also discussed are forensic and legal issues for the pathologist concerning agents of biological terrorism and biological warfare, the concept of chain of custody, transport, storage, and biosafety levels. It defines the importance of the pathologist in managing the threat posed by biological weapons.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Alibek K.
        • Handelman S.
        Biohazard. Random House, New York1999
        • Anonymous
        Outbreak of Hendra-like virus—Malaysia and Singapore, 1998-1999.
        MMWR Morb Mortal Wkly Rep. 1999; 48: 265-269

      3. Anthrax, human and livestock - Zimbabwe (03). ProMED-Mail: promed@promed.isid.harvard.edu

        • Barréé-Sinoussi F.
        • Chermann J.C.
        • Rey F.
        • et al.
        Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome.
        Science. 1983; 220: 868-871
        • Bishop R.F.
        • Davidson G.P.
        • Holmes I.H.
        • et al.
        Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis.
        Lancet. 1973; 2: 1281-1283
        • Bowles J.
        • McManus D.P.
        Genetic characterization of the Asian Taenia: A newly described taeniid cestode of humans.
        Am J Trop Med Hyg. 1994; 50: 33-44
        • Buller R.S.
        • Arens M.
        • Hmiel S.P.
        • et al.
        Ehrlichia ewingii: A newly recognized agent of human ehrlichiosis.
        N Engl J Med. 1999; 341: 148-155
        • Burgdorfer W.
        • Barbour A.G.
        • Hayes S.F.
        • et al.
        Lyme disease: A tick-borne spirochetosis?.
        Science. 1982; 216: 1317-1319

      9. Carus WS: Bioterrorism and Biocrimes. The Illicit Use of Biological Agents in the 20th Century. Washington, DC, Center for Counterproliferation Research, National Defense University, 1998, revised 1999

        • Centers for Disease Control and Prevention
        Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States. US Department of Health and Human Services, Public Health Service, Atlanta, GA1994
        • Centers for Disease Control and Prevention
        Biological and chemical terrorism: Strategic plan for preparedness and response: Recommendations of the CDC strategic planning workgroup.
        MMWR. 2000; 49: 1-14
        • Centers for Disease Control and Prevention
        Human ingestion of Bacillus anthracis- contaminated meat—Minnesota, August 2000.
        MMWR. 2000; 49: 813-816
        • Cerf M.
        • Marche C.
        • Ciribilli J.M.
        Whipple disease: A single or multiple origin?.
        Presse Med. 1995; 24: 119-120
        • Chang Y.
        • Cesarman E.
        • Pessin M.S.
        • et al.
        Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma.
        Science. 1994; 266: 1865-1869
      15. Cholera in the Americas.
        Epidemiol Bull. 1995; 16: 11
        • Choo Q.L.
        • Kuo G.
        • Weiner A.J.
        • et al.
        Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.
        Science. 1989; 244: 359-361

      17. Cohen WS: Preparing for a grave new world. The Washington Post July 26, 1999, p A19

        • Cossart Y.E.
        • Field A.M.
        • Cant B.
        • et al.
        Parvovirus-like particles in human sera.
        Lancet. 1975; 1: 72-73
        • Davis C.J.
        Nuclear blindness: An overview of the biological weapons programs of the former Soviet Union and Iraq.
        Emerg Infect Dis. 1999; 5: 509-512
        • Dawson J.E.
        • Anderson B.E.
        • Fishbein D.B.
        • et al.
        Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis.
        J Clin Microbiol. 1991; 29: 2741-2745
        • Elliott L.H.
        • Ksiazek T.G.
        • Rollin P.E.
        • et al.
        Isolation of the causative agent of hantavirus pulmonary syndrome.
        Am J Trop Med Hyg. 1994; 51: 102-108

      22. First annual report to the President and the Congress of the advisory panel to assess domestic capabilities for terrorism involving weapons of mass destruction: 1 - assessing the threat. The Rand Corporation. December 15, 1999. http://www.rand.org/organization/nsrd/terrpanel/terror.pdf.

        • Fox J.G.
        • Chien C.C.
        • Dewhirst F.E.
        • et al.
        Helicobacter canadensis sp. nov. isolated from humans with diarrhea as an example of an emerging pathogen.
        J Clin Microbiol Jul. 2000; 38: 2546-2549
        • Harris S.H.
        Factories of Death. Routledge, New York1994
        • Holum J.D.
        Remarks for the Fourth Review Conference of the Biological Weapons Convention. US Arms Control and Disarmament Agency, Geneva1996
        • Johnson K.M.
        • Webb P.A.
        • Lange J.V.
        • et al.
        Isolation and partial characterization of a new virus causing acute haemorrhagic fever in Zaire.
        Lancet. 1977; 1: 569-571
        • Kalyanaraman S.
        • Sarangadharan M.G.
        • Poiesz B.
        • et al.
        Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses.
        J Virol. 1981; 38: 906-915
        • Khan A.S.
        • Tshioko F.K.
        • Heymann D.L.
        • et al.
        The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit.
        J Infect Dis. 1999; 179: S76-86
        • Knapp S.
        • Hacker J.
        • Jarchau T.
        • et al.
        Large, unstable inserts in the chromosome affect virulence properties of uropathogenic Escherichia coli 06 strain 536.
        J Bacteriol. 1986; 168: 22-30
        • Kortepeter M.G.
        • Parker G.W.
        Potential biological weapons threats.
        Emerg Infect Dis. 1999; 5: 523-527
        • Lee H.W.
        • Lee P.W.
        • Johnson K.M.
        Isolation of the etiologic agent of Korean hemorrhagic fever.
        J Infect Dis. 1978; 137: 298-308
        • Lisieux T.
        • Coimbra M.
        • Nassar E.S.
        • et al.
        New arenavirus isolated in Brazil.
        Lancet. 1994; 343: 391-392
        • Lo S.C.
        • Hayes M.M.
        • Wang R.Y.
        • et al.
        Newly discovered mycoplasma isolated from patients infected with HIV.
        Lancet. 1991; 338: 1415-1418
        • MacDonald R.
        Ebola virus claims more lives in Uganda.
        BMJ. 2000; 321: 1037
        • MacKenzie W.R.
        • Hoxie N.J.
        • Proctor M.E.
        • et al.
        A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply.
        N Engl J Med. 1994; 331: 161-167
        • MacKenzie W.R.
        • Schell W.L.
        • Blair K.A.
        • et al.
        Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: Recurrence of illness and risk of secondary transmission.
        Clin Infect Dis. 1995; 21: 57-62
        • Marshall B.
        Comment.
        Lancet. 1983; 1: 1273-1275
        • McDade J.E.
        • Shepard C.C.
        • Fraser D.W.
        • et al.
        Legionnaires’ disease. 2: Isolation of a bacterium and demonstration of its role in other respiratory disease.
        N Engl J Med. 1977; 297: 1197-1203
        • Meselson M.
        • Gillemin J.
        • Hugh-Jones M.
        • et al.
        The Sverdlovsk anthrax outbreak of 1979.
        Science. 1994; 209: 1202-1208
        • Nichol S.T.
        • Spiropoulou C.F.
        • Morzunov S.
        • et al.
        Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness.
        Science. 1993; 262: 914-917
        • Nime F.A.
        • Burek J.D.
        • Page D.L.
        • et al.
        Acute enterocolitis in a human being infected with the protozoan Cryptosporidium.
        Gastroenterology. 1976; 70: 592-598
        • Poiesz B.J.
        • Ruscetti F.W.
        • Gazdar A.F.
        • et al.
        Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.
        Proc Natl Acad Sci USA. 1980; 77: 7415-7419
        • Reiman D.A.
        • Schmidt T.M.
        • MacDermott R.P.
        • et al.
        Identification of the uncultured bacillus of Whipple’s disease.
        N Engl J Med. 1992; 327: 293-301
        • Riley L.W.
        • Remis R.S.
        • Helgerson S.D.
        • et al.
        Hemorrhagic colitis associated with a rare Escherichia coli serotype.
        N Engl J Med. 1983; 308: 681-685
        • Salas R.
        • de Manzione N.
        • Tesh R.B.
        • et al.
        Venezuelan hemorrhagic fever.
        Lancet. 1991; 338: 1033-1036
        • Schlievert P.M.
        • Shands K.N.
        • Gan B.B.
        • et al.
        Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome.
        J Infect Dis. 1981; 143: 509-516
        • Simon J.D.
        Biological terrorism: Preparing to meet the threat.
        JAMA. 1997; 278: 428-430
        • Skirrow M.B.
        Campylobacter enteritis: A new disease.
        BMJ. 1977; 2: 9-11

      49. Today in Medicine. Global HIV infections exceed predictions by 50%. 29 November 2000 http://home.mdconsult.com/das/stat/view/mnfp

      50. Urbanetti JS: Biological Agent of the Month: Anthrax. Jane’s Chem-Bio. Jan 11, 2000 http://chembio.janes.com

      51. Venter AIJ. Sverdlovsk Outbreak: A Portend of Disaster. Jane’s Intelligence Review, May 1 1998:36 http://jir.janes.com

        • Welch D.F.
        • Pickett D.A.
        • Slater L.N.
        • et al.
        Rochalimaea henselae sp. nov: a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis.
        J Clin Microbiol. 1992; 30: 275-280
        • World Health Organization
        Epidemic diarrhea due to Vibrio cholerae non-01.
        Wkly Epidemiol Rec. 1993; 68: 141-142
        • Yamamoto T.
        • Kajino K.
        • Ogawa M.
        • et al.
        Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration.
        Biochem Biophys Res Commun. 1998; 251: 339-343
        • Yamanishi K.
        • Okuno T.
        • Shiraki K.
        • et al.
        Identification of human herpesvirus-6 as a causal agent for exanthem subitum.
        Lancet. 1988; 1: 1065-1067
        • Zilinskas R.A.
        Iraq’s biological weapons, the past as future?.
        JAMA. 1997; 278: 418-424

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30016-7

      Copyright

      © 2001 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX